ACE and coronary artery disorder: Our previous study showed that in Chinese hospitals, the use of antiplatelet agents and statins was optimal, but the use of β-blockers and ACE inhibitors/ARBs was underutilized at discharge in patients with CHD (Xu et al., 2014).